Qvt Financial LP Aadi Bioscience, Inc. Transaction History
Qvt Financial LP
- $1.02 Billion
- Q2 2025
A detailed history of Qvt Financial LP transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Qvt Financial LP holds 4,615,709 shares of AADI stock, worth $7.89 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
4,615,709
Previous 4,515,709
2.21%
Holding current value
$7.89 Million
Previous $8.04 Million
1.8%
% of portfolio
0.77%
Previous 0.85%
Shares
3 transactions
Others Institutions Holding AADI
# of Institutions
42Shares Held
30MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA4.17MShares$7.12 Million0.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.7MShares$6.33 Million0.22% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA3.41MShares$5.83 Million14.49% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.09% of portfolio
-
Siren, L.L.C. New York, NY2.08MShares$3.56 Million0.2% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...